北美炭疽病治疗市场报告 - 行业趋势和预测至2029年

北美炭疽病治疗市场，按类型（皮肤炭疽病、肺炭疽病和肠炭疽病）、给药途径（口服、肠外和其他）、最终用户（政府组织、医院、学术和研究机构等）划分的行业趋势和预测到 2029 年。

北美炭疽病治疗市场

北美炭疽病治疗市场分析与洞察

北美炭疽病治疗市场受到多种因素的推动，例如细菌感染发病率上升、研究资金增加、炭疽病治疗新疗法的开发和管道产品增加了对炭疽病治疗的需求，以及研发投资的增加导致市场增长。目前，发达国家和新兴国家的医疗保健支出都有所增加，这有望为制造商开发新的创新产品创造竞争优势。

北美炭疽病治疗市场

全球患炭疽病的人数增加是推动炭疽病治疗市场增长的主要因素之一。研究人员为开发新型干预措施而获得的财政支持增加，以及平民和军队接触炭疽杆菌的威胁增加，加速了市场的增长。研发项目数量的增加，以及为促进创新和有效治疗的新发展而建立的公私伙伴关系的增加，进一步影响了市场。然而，治疗和程序的高成本以及政府对产品审批的严格规定预计将阻碍炭疽病治疗市场的增长。

北美炭疽病治疗市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入来源、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情景，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。各地区发展中国家零售单位的可扩展性和业务扩展以及与供应商合作安全分销机器和药品是推动预测期内市场需求的主要驱动力。

北美炭疽病治疗市场具有支持性，旨在减缓疾病的进展。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，北美炭疽病治疗市场将以 4.2% 的复合年增长率增长。

报告指标	细节
预测期	2022 至 2029 年
基准年	2021
历史岁月	2020（可定制至 2019 - 2014）
定量单位	收入（百万美元），定价（美元）
涵盖的领域	按类型（皮肤炭疽、肺炭疽和肠炭疽）、给药途径（口服、肠外和其他）、最终用户（政府组织、医院、学术和研究机构和其他）划分的行业趋势和预测（至 2029 年）
覆盖国家	美国、加拿大、墨西哥
涵盖的市场参与者	Alembic Pharmaceuticals、Integrated Bio Therapeutics Inc.、Sun Pharmaceutical Industries Ltd.、Zydus Group、Bayer AG、Pfizer Inc.、EMERGENT、Sanofi、Elusys Therapeutics、Lupin、Soligenix、Takeda Pharmaceutical Company Limited、Teva Pharmaceutical Industries Ltd.、INDOCO REMEDIES LTD.、Paratek Pharmaceuticals, Inc.、BlueWillow Biologics.、Altimmune 等

北美炭疽病治疗市场动态

市场定义

炭疽病是由一种名为炭疽芽孢杆菌 (B. anthracis) 的细菌引起的。它主要是一种牲畜疾病，通过摄入土壤中的孢子而感染。人类通常通过接触受感染动物的产品（如皮革或羊毛）或吸入受感染动物产品中的炭疽孢子而感染炭疽病。他们也可能通过食用受感染动物的未煮熟的肉而感染。据了解，炭疽病不会在人与人之间传播。

炭疽感染有三种临床形式。皮肤炭疽是最常见的，占已报告病例的 95% 以上。据估计，全球每年发生 2000 例皮肤炭疽病例，是由孢子通过皮肤擦伤进入人体引起的。

炭疽病的鉴别诊断包括根据临床特征，相关标本包括PCR、革兰氏染色和培养，来自血液、胸腔积液、溃疡部位、脑脊液和粪便。有许多可用的技术。大多数检测是基于通过以下技术之一检测整个生物体、生物体抗原或生物体核酸：基于培养的常规方法；免疫学检测；基于核酸的检测；基于配体的检测；以及生物传感器。

驱动程序

炭疽病感染率不断上升

细菌感染的发病率在世界范围内不断上升。炭疽病是由炭疽芽孢杆菌引起的细菌感染，炭疽芽孢杆菌是一种需氧革兰氏阳性芽孢杆菌。根据炭疽芽孢杆菌孢子的进入途径，炭疽病主要以皮肤、肺部或胃肠道感染的形式出现。随后，受感染的皮肤区域会出现典型的黑色硬皮斑点，几周后开始松弛并最终脱落，留下疤痕。这些事件的进程非常典型，熟悉该疾病的医生通常不会漏诊，尽管这种情况很少见。肺炭疽是三种炭疽病中最致命的一种，其中的孢子一旦被吸入，就会在气管支气管淋巴结内发芽并繁殖。炭疽病是一种影响人类和动物的有害疾病。它是一种由炭疽芽孢杆菌引起的危及生命的感染。因此，炭疽病感染的发病率和流行率不断上升，需要更多灵敏度更高的诊断方法来检测少量感染。

全球患炭疽病的人数增加是推动炭疽病治疗市场增长的主要因素之一。研究人员为开发新型干预措施而获得的财政支持增加，以及平民和军队接触炭疽杆菌的威胁增加，加速了市场的增长。研发项目数量的增加，以及促进创新有效治疗的新发展的公私伙伴关系的增加，进一步影响了市场。

增加研究资金和开发针对炭疽病治疗人群的新疗法

研发是改进治疗不同类型患者的程序的先决条件。全球各国对炭疽病治疗的需求都在增加。这就是为什么各公司不断专注于研发，以成功为患者提供有效的治疗。近年来，许多诊断方法的出现将诊断提升到了新的水平，许多方法甚至可以用来检测人体内最小量的寄生虫。

这些新的诊断方法将推动市场向前发展。随着研究资金的增加和治疗炭疽病的新疗法的开发。有几种新型和现有的抗生素以及毒素抑制剂显示出越来越大的前景，它们针对细菌生长和毒素产生，有效对抗炭疽细菌。

随着公司不断从事开发活动，市场上推出了更多创新产品。开发的新工具能够以更高的有效率在更短的时间间隔内检测出细菌感染，从而使消费者能够在正确的时间获得适当的治疗。因此，这意味着增加研发有望成为北美炭疽病治疗市场增长的动力

机会

新品发布

人类感染通常是通过接触受感染的动物或动物产品，并可能表现为皮肤、吸入或胃肠道感染。炭疽病的全球发病率普遍上升。因此，全球越来越多的患者需要高效和先进的炭疽病治疗产品，以最大限度地降低因炭疽病死亡的风险。此外，发达国家的医疗保健系统更倾向于高进步、风险因素较少和先进的炭疽病治疗产品。因此，主要市场参与者高度关注产品发布。

因此，不断增加的产品发布提供了高效和先进的医疗产品，以改善患者体验。新产品的发布不仅引起了公司的关注，还为公司在北美市场建立了影响力。产品发布的根本有利因素是促进了公司的业务增长。而新产品的发布为公司创造了收入来源，而产品发布所建立的收入来源可以持续多年。因此，据估计，新产品的发布有望为市场参与者带来巨大的机会，以提升他们在炭疽病治疗市场的业务增长。

限制/挑战

治疗费用高昂

产品成本是市场的主要因素。市场上有许多诊断选项，但由于成本高昂，大多数人倾向于避免进行诊断。由于诊断方法具有更高的灵敏度和特异性，因此测试成本也增加了。该程序的高成本是由于治疗的各种检查点以及使用高科技方式执行此类程序。由于技术先进设备的成本很高，因此程序成本也会相应增加，因此预计程序的高成本将阻碍市场的需求。

此外，无症状感染者必须经过非常特殊的测试才能识别出细菌，而这些测试成本高昂。由于炭疽病的诊断成本高昂，预计会抑制市场增长。由于识别治疗的成本过高，限制了医生和患者接受高质量和有效的解决方案。因此，治疗程序的高成本对整体治疗成本产生负面影响。因此，它将限制未来中低收入国家对治疗的需求。这表明，高成本的程序预计将成为北美炭疽病治疗市场增长的制约因素。

近期发展

2022 年 6 月，Emergent BioSolutions Inc. 宣布，美国食品药品监督管理局 (FDA) 接受了 AV7909 的生物制品许可申请 (BLA) 的审查，AV7909 是一种新的炭疽候选疫苗，用于评估 18 至 65 岁人群在疑似或确诊接触炭疽杆菌后，使用推荐的抗菌药物进行暴露后预防疾病。
2022 年 1 月，Alembic Pharmaceuticals Limited 宣布，该公司已获得美国食品药品监督管理局 (USFDA) 对其盐酸多西环素缓释片 USP、75 毫克、100 毫克、150 毫克和 200 毫克的简化新药申请 (ANDA) 的最终批准，该药仅用于治疗或预防已证实或强烈怀疑由易感细菌引起的感染。这扩大了公司的产品组合。

北美炭疽病治疗市场细分

北美炭疽治疗市场根据类型、给药途径和最终用户分为三个显著的细分市场。细分市场之间的增长有助于您分析利基增长点和进入市场的策略，并确定您的核心应用领域和目标市场的差异。

类型

皮肤炭疽
肺炭疽
肠炭疽

根据类型，北美炭疽病治疗市场分为皮肤炭疽病、肺炭疽病和肠炭疽病。

给药途径

皮肤炭疽
肺炭疽
肠炭疽

根据给药途径，北美炭疽病治疗市场分为口服、肠外和其他途径。

最终用户

政府组织
医院
学术及研究机构，
其他的

炭疽病治疗市场

根据最终用户，北美炭疽病治疗市场分为政府组织、医院、学术和研究机构等。

炭疽病治疗市场区域分析/见解

对北美炭疽病治疗市场进行了分析，并按类型、给药途径和最终用户提供了市场规模洞察和趋势。

炭疽病治疗报告涉及的国家包括美国、加拿大和墨西哥。

由于发展中地区的技术进步日益加快，美国有望占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和炭疽病治疗市场份额分析

北美炭疽病治疗市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对炭疽病治疗市场的关注有关。

市场的一些参与者包括 Alembic Pharmaceuticals、Integrated Bio Therapeutics Inc.、Sun Pharmaceutical Industries Ltd.、Zydus Group、Bayer AG、Pfizer Inc.、EMERGENT、Sanofi、Elusys Therapeutics、Lupin、Soligenix、Takeda Pharmaceutical Company Limited、Teva Pharmaceutical Industries Ltd.、INDOCO REMEDIES LTD.、Paratek Pharmaceuticals, Inc.、BlueWillow Biologics.、Altimmune 等。

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、北美与地区和供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-68922

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 POPULATION AT RISK (IN MILLIONS) BY REGION, LAND USE AND OCCUPATIONAL EXPOSURE, 2020-

TABLE 2 VACCINES IN DEVELOPMENT

TABLE 3 ANTIBIOTIC CONSUMPTION ESTIMATES BY GBD SUPER-REGION AND GBD REGION, FOR THE YEAR 2018-

TABLE 4 COUNTRY DATA OF ANTIBIOTICS CONSUMPTION-

TABLE 5 RECENT M&A IN ANTHRAX MARKET-

TABLE 6 ANTIBIOTICS MEDICINES

TABLE 7 FDA REQUIRES THE FOLLOWING SCENARIO BEFORE A DRUG IS APPROVED

TABLE 8 NORTH AMERICA ANTHRAX TREATMENT MARKET, TYPE, 2020-2029 (USD MILLION)

TABLE 9 NORTH AMERICA CUTANEOUS ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 NORTH AMERICA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 11 NORTH AMERICA ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 13 NORTH AMERICA BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 14 NORTH AMERICA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 15 NORTH AMERICA ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 16 NORTH AMERICA VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 17 NORTH AMERICA PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 NORTH AMERICA PULMONARY ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 19 NORTH AMERICA ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 20 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 21 NORTH AMERICA BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 22 NORTH AMERICA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 23 NORTH AMERICA ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 24 NORTH AMERICA VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 25 NORTH AMERICA INTESTINAL ANTHRAX IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 NORTH AMERICA INTESTINAL ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 27 NORTH AMERICA ANTIBIOTICS IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 28 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 29 NORTH AMERICA BY PRODUCT TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 30 NORTH AMERICA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 31 NORTH AMERICA ANTITOXIN IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 32 NORTH AMERICA VACCINES IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 33 NORTH AMERICA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD MILLION)

TABLE 34 NORTH AMERICA PARENTERAL IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 NORTH AMERICA ORAL IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 NORTH AMERICA OTHERS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 NORTH AMERICA ANTHRAX TREATMENT MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 38 NORTH AMERICA GOVERNMENT ORGANIZATION IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 NORTH AMERICA HOSPITALS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 NORTH AMERICA ACADEMIC AND RESEARCH IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 NORTH AMERICA OTHERS IN ANTHRAX TREATMENT MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 NORTH AMERICA ANTHRAX TREATMENT MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 43 NORTH AMERICA ANTHRAX TREATMENT MARKET, BY TYPE , 2020-2029 (USD MILLION)

TABLE 44 NORTH AMERICA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 45 NORTH AMERICA ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 46 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 47 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 48 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 49 NORTH AMERICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 50 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 51 NORTH AMERICA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 52 NORTH AMERICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 53 NORTH AMERICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 54 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 55 NORTH AMERICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 56 NORTH AMERICA VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 57 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 58 NORTH AMERICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 59 NORTH AMERICA PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 60 NORTH AMERICA ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 61 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 62 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 63 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 64 NORTH AMERICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 65 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 66 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 67 NORTH AMERICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 68 NORTH AMERICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 69 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 70 NORTH AMERICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 71 NORTH AMERICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 72 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 73 NORTH AMERICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 74 NORTH AMERICA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 75 NORTH AMERICA ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 76 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 77 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 78 NORTH AMERICA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 79 NORTH AMERICA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 80 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 81 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 82 NORTH AMERICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 83 NORTH AMERICA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 84 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 85 NORTH AMERICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020-2029 (ASP)

TABLE 86 NORTH AMERICA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 87 NORTH AMERICA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 88 NORTH AMERICA BRANDED TYPES ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (ASP)

TABLE 89 NORTH AMERICA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 90 NORTH AMERICA ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 91 U.S. ANTHRAX TREATMENT MARKET, BY TYPE , 2020-2029 (USD MILLION)

TABLE 92 U.S. CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 93 U.S. ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 94 U.S. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 95 U.S. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 96 U.S. BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 97 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 98 U.S. BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 99 U.S. ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 100 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 101 U.S. VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 102 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 103 U.S. PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 104 U.S. ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 105 U.S. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 106 U.S. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 107 U.S. BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 108 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 109 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 110 U.S. ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 111 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 112 U.S. VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 113 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 114 U.S. INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 115 U.S. ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 116 U.S. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 117 U.S. BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 118 U.S. BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 119 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 120 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 121 U.S. ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 122 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 123 U.S. VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 124 U.S. BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 125 U.S. ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 126 U.S. ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 127 CANADA ANTHRAX TREATMENT MARKET, BY TYPE , 2020-2029 (USD MILLION)

TABLE 128 CANADA CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 129 CANADA ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 130 CANADA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 131 CANADA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 132 CANADA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 133 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 134 CANADA BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 135 CANADA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 136 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 137 CANADA VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 138 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 139 CANADA PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 140 CANADA ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 141 CANADA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 142 CANADA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 143 CANADA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 144 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 145 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 146 CANADA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 147 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 148 CANADA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 149 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 150 CANADA INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 151 CANADA ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 152 CANADA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 153 CANADA BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 154 CANADA BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 155 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 156 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 157 CANADA ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 158 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 159 CANADA VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 160 CANADA BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 161 CANADA ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 162 CANADA ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

TABLE 163 MEXICO ANTHRAX TREATMENT MARKET, BY TYPE , 2020-2029 (USD MILLION)

TABLE 164 MEXICO CUTANEOUS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 165 MEXICO ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 166 MEXICO BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 167 MEXICO BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 168 MEXICO BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 169 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 170 MEXICO BRANDED IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 171 MEXICO ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 172 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 173 MEXICO VACCINE IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 174 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 175 MEXICO PULMONARY ANTHRAX IN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 176 MEXICO ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 177 MEXICO BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 178 MEXICO BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 179 MEXICO BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 180 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 181 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 182 MEXICO ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 183 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 184 MEXICO VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 185 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 186 MEXICO INTESTINAL ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 187 MEXICO ANTIBIOTIC ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 188 MEXICO BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 189 MEXICO BY DRUGS ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 190 MEXICO BY PRODUCT TYPE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 191 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 192 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 193 MEXICO ANTITOXIN ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 194 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 195 MEXICO VACCINE ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (USD MILLION)

TABLE 196 MEXICO BRANDED ANTHRAX TREATMENT MARKET, BY TYPE, 2020- 2029 (UNITS)

TABLE 197 MEXICO ANTHRAX TREATMENT MARKET, BY ROUTE OF ADMINISTRATIONS, 2020- 2029 (USD MILLION)

TABLE 198 MEXICO ANTHRAX TREATMENT MARKET, BY END USER, 2020- 2029 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA ANTHRAX TREATMENT MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA ANTHRAX TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA ANTHRAX TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA ANTHRAX TREATMENT MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 NORTH AMERICA ANTHRAX TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA ANTHRAX TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA ANTHRAX TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA ANTHRAX TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 NORTH AMERICA ANTHRAX TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA ANTHRAX TREATMENT MARKET: SEGMENTATION

FIGURE 11 MIDDLE EAST & AFRICA IS ANTICIPATED TO DOMINATE THE ANTHRAX TREATMENT MARKET AND GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 INCREASING INCIDENCE AND PREVALENCE OF ANTHRAX INFECTIONS ARE EXPECTED TO DRIVE THE NORTH AMERICA ANTHRAX TREATMENT MARKET IN THE FORECAST PERIOD

FIGURE 13 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ANTHRAX TREATMENT MARKET IN 2022 & 2029

FIGURE 14 NORTH AMERICA DISTRIBUTION OF OUTBREAKS BY COUNTRY AND GEOGRAPHIC LOCATIONS OF ANTHRAX EVENTS-

FIGURE 15 PATHOPHYSIOLOGY OF ANTHRAX-

FIGURE 16 FLOW CHART FOR SUSPECTED ANTHRAX EXPOSURE-

FIGURE 17 GC BIOPHARMA ANTHRAX CANDIDATE GC1109 IS IN PHASE 2 (NCT01624532).

FIGURE 18 BA-ISTAB IS A FUSION OF A B. ANTHRACIS SPECIFIC CWT WITH A POTENT MONOCLONAL ANTIBODY THAT NEUTRALIZE ANTHRAX TOXIN (PA).

FIGURE 19 TWO ROUTES BY WHICH VACCINATION CAN REDUCE INCIDENCE OF AMR-

FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA ANTHRAX TREATMENT MARKET

FIGURE 21 NORTH AMERICA ANTHRAX TREATMENT MARKET : TYPE, 2021

FIGURE 22 NORTH AMERICA ANTHRAX TREATMENT MARKET : TYPE, 2022-2029 (USD MILLION)

FIGURE 23 NORTH AMERICA ANTHRAX TREATMENT MARKET : TYPE, CAGR (2022-2029)

FIGURE 24 NORTH AMERICA ANTHRAX TREATMENT MARKET : TYPE, LIFELINE CURVE

FIGURE 25 NORTH AMERICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, 2021

FIGURE 26 NORTH AMERICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, 2022-2029 (USD MILLION)

FIGURE 27 NORTH AMERICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)

FIGURE 28 NORTH AMERICA ANTHRAX TREATMENT MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 29 NORTH AMERICA ANTHRAX TREATMENT MARKET : BY END USER, 2021

FIGURE 30 NORTH AMERICA ANTHRAX TREATMENT MARKET : BY END USER, 2022-2029 (USD MILLION)

FIGURE 31 NORTH AMERICA ANTHRAX TREATMENT MARKET : BY END USER, CAGR (2022-2029)

FIGURE 32 NORTH AMERICA ANTHRAX TREATMENT MARKET : BY END USER, LIFELINE CURVE

FIGURE 33 NORTH AMERICA ANTHRAX TREATMENT MARKET: SNAPSHOT (2021)

FIGURE 34 NORTH AMERICA ANTHRAX TREATMENT MARKET: BY COUNTRY (2021)

FIGURE 35 NORTH AMERICA ANTHRAX TREATMENT MARKET: BY COUNTRY (2022 & 2029)

FIGURE 36 NORTH AMERICA ANTHRAX TREATMENT MARKET: BY COUNTRY (2021 & 2029)

FIGURE 37 NORTH AMERICA ANTHRAX TREATMENT MARKET: BY TYPE (2022-2029)

FIGURE 38 NORTH AMERICA ANTHRAX TREATMENT MARKET: COMPANY SHARE 2021(%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

北美炭疽病治疗市场 - 行业趋势和 2029 年预测

北美炭疽病治疗市场 - 行业趋势和 2029 年预测

北美炭疽病治疗市场分析与洞察

北美炭疽病治疗市场动态

北美炭疽病治疗市场细分

炭疽病治疗市场区域分析/见解

竞争格局和炭疽病治疗市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

报告

市场洞察

支持

解决方案

北美炭疽病治疗市场 - 行业趋势和 2029 年预测

北美炭疽病治疗市场 - 行业趋势和 2029 年预测

北美炭疽病治疗市场分析与洞察

北美炭疽病治疗市场动态

北美炭疽病治疗市场细分

炭疽病治疗市场区域分析/见解

竞争格局和炭疽病治疗市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

浏览相关页面